3050 GLP-1 GLP-1GLP-1FDAEUKFDA GLP-1 GLP-1 GLP-1 4 1
Archived from the original on August 30, 2018
Melanotan 2 was developed at the University of Arizona in order to find a synthetic variant of the hormone -MSH so that it can be researched and used for therapeutic purposes, as the natural hormone -MSH has a very short half-life
Additionally, her hyperphagia was quite severe, and medications with stronger mechanisms for appetite regulation (like GLP-1 RAs) were ultimately more impactful. Despite extensive evaluation for monogenic and syndromic causes of hyperphagia, a clear diagnosis was not reached
Did my first injection on July 6
The most common adverse effects reported during clinical trials with exenatide are gastrointestinal symptoms including vomiting, nausea, and diarrhea, as well as mild to moderate hypoglycemia [44,49-51]